VALO Health, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 170
Rang # Quantité totale PI 7 623
Note d'activité PI 2,9/5.0    121
Rang # Activité PI 5 675
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

127 5
13 0
21 4
0
 
Dernier brevet 2025 - Systems and methods for event-ba...
Premier brevet 2003 - Method and apparatus for molecul...
Dernière marque 2022 - LOGICA-AL
Première marque 2008 - NUMERATE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Systems and methods for event-based tissue activity quantification. Systems and methods for event...
Invention System and method for target or biomarker identification. A method for identifying key targets or...
Invention Systems and methods for automated assessment of artificial tissue. Systems and methods are descri...
Invention Lipotoxic media. The invention provides culture media for cultivating cardiac tissue, methods of ...
Invention Isoindolinone-containing parp inhibitors and methods of use. The present disclosure relates to co...
Invention Spirocyclic parp inhibitors and methods of use. The present disclosure relates to compounds accor...
Invention Homophthalazinone indole parp inhibitors and methods of use. The present disclosure relates to co...
Invention Benzamidazole diazapinone parp inhibitors and methods of use. The present disclosure relates to c...
Invention Process for preparing 6-substituted-1-(2h)-isoquinolinones and intermediate compound. The invent...
Invention Systems and methods regarding peak exploration and artificial tissue response including for contr...
Invention Systems and methods regarding peak exploration and artificial tissue response including for tissu...
Invention Systems and methods regarding peak exploration and artificial tissue response including for proce...
Invention Systems and methods regarding peak exploration and artificial tissue response including for detec...
Invention Selective fiasma treatment. This disclosure concerns a method of treating or preventing a disease...
Invention Invertible models of cardiac function. Systems and methods are described herein for predicting ch...
2023 Invention Spectral encoding of tissue behavior. Systems, methods, and non-transitory computer readable medi...
Invention System and method for predicting and optimizing clinical trial outcomes. A vector associated with...
Invention Artificial skeletal muscle tissue. Embodiments described herein relate generally to a three-dime...
Invention Biomarker combinations for prognosis and management of diabetic retinopathy. Methods are describe...
Invention H)-isoquinolinones and intermediate compound. The invention relates to substituted 6-substituted ...
Invention 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors. The present invention is directed to...
Invention Tricyclic phthalazinone parp inhibitors and methods of use. The present disclosure relates to com...
Invention Bicyclic [4,6,0] hydroxamic acids as hdac inhibitors. The present invention relates to inhibitor...
Invention Artificial skeletal muscle tissue. Embodiments described herein relate generally to a three-dimen...
Invention [6,6] fused bicyclic hdac8 inhibitors. The present invention is directed to compounds of Formula...
2022 Invention Novel compounds and compositions for the inhibition of nampt. The present invention relates to c...
Invention Isoindolines as hdac inhibitors. The present disclosure relates to inhibitors of zinc-dependent ...
Invention Histone deacetylase 6 inhibitor compounds and uses thereof. The present disclosure provides compo...
P/S Pharmaceutical drug development services; pharmaceutical drug development services via software ...
Invention Monocyclic compounds useful as gpr120 modulators. Provided herein are compounds, compositions inc...
Invention Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransfer...
P/S Pharmaceutical drug development services; Pharmaceutical drug development services via software u...
Invention Methods using hdac11 inhibitors. The present invention provides methods and uses of inhibitors o...
Invention 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors. The present disclosure relat...
2021 Invention 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors. The present disclosure rela...
Invention Alpha-cinnamide compounds and compositions as hdac8 inhibitors. The present invention relates to ...
Invention Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors. The invent...
Invention Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors. The invention relate...
Invention Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific p...
Invention Integrated system for 3d tissue culture. Embodiments described herein relate generally to device...
Invention Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors. The disclosure relates to inhib...
2020 Invention Bicyclic compounds useful as gpr120 modulators. Provided herein are compounds, compositions inclu...
Invention Compounds and compositions for the inhibition of nampt. The present invention relates to compound...
Invention Inhibiting usp19. The present disclosure is directed to compounds of formulas (I)-(VI), which ar...
Invention Inhibiting trabid. The present disclosure is directed to compounds of formulas (I)-(VII), which ...
Invention Inhibiting usp36. The present disclosure is directed to compounds of formulas (I)-(VI), which ar...
Invention A microphysiological platform with embedded electrodes for 3d tissue culture. Embodiments descri...
Invention Carboxamides as ubiquitin-specific protease inhibitors. The present disclosure relates to modulat...
2019 P/S Cell and tissue culture services, namely, custom design and development of muscle, vascular, and...
Invention Isoindolines as hdac inhibitors. 3, L, Z, and R are described herein.
P/S Cell and tissue culture services, namely, custom design and development of muscle, vascular, and ...
2008 P/S Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical...